NL-OMON24912招募中3 期
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018
German Pediatric Oncology Group (GPOH)0 个研究点目标入组 10 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 11（—）
入选标准
- •- Myeloïde leukemie (ML) of Myelodysplastisch Syndroom (MDS), volgens de WHO.
- •- Trisomie 21: syndroom van Down of mosaic.
排除标准
- •- Kinderen met ‘Transient Abnormal Myelopoiesis (TAM), volgens de WHO. |
研究者
相似试验
招募中
3 期
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018NL-OMON55026German Pediatric Oncology Group (GPOH) gGmbH10
进行中（未招募）
1 期
Clinical Trial for the Treatment of Myeloid Leukemia in Children with Down SyndromeEUCTR2018-002988-25-DEGesellschaft für Pädiatrische Onkologie & Hämatologie (GPOH gGmbH)150
进行中（未招募）
1 期
Clinical Trial for the Treatment of Myeloid Leukemia in Children with Down SyndromeMyeloid Leukemia in Children with Down SyndromeEUCTR2018-002988-25-NLGesellschaft für Pädiatrische Onkologie & Hämatologie (GPOH gGmbH)150
进行中（未招募）
1 期
Clinical Trial for the Treatment of Myeloid Leukemia in Children with Down SyndromeEUCTR2018-002988-25-ATGesellschaft für Pädiatrische Onkologie & Hämatologie (GPOH gGmbH)150
进行中（未招募）
1 期
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018Myeloid Leukemia in Children with Down SyndromeCTIS2022-501457-37-00GPOH gGmbH185